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Identity 
Other names: CBAS3; CP7B; SPG5A; CYP7B 
HGNC (Hugo): CYP7B1 
Location: 8q21.3 
Note 
CYP7B1 is a steroid hydroxylase involved in meta-
bolism of sex hormones, oxysterols (a type of 
cholesterol derivatives) and neurosteroids. 
DNA/RNA 
Description 
The human CYP7B1 DNA maps to NM_004820 
(Entrez-Gene) and spans a region of 202.66 kB. 
CYP7B1 is located on chromosome 8 and consists of 
six exons. 
Transcription 
The full length CYP7B1 mRNA is 2,395 bp with an 
open reading rame of 1,521 bp. 
 
Pseudogene 
No pseudogenes reported. 
Protein 
Description 
The human CYP7B1 protein consists of 506 amino 
acids and has a molecular weight of 58,256. The N-
terminal membrane-binding domain (residues 1 to 38) 
is highly hydrophobic. The ATG start codon is located 
204 nucleotides downstream of the trans-cription start 
site (Wu et al., 1999). Similarly as other members of 
the cytochrome P450 (CYP) enzyme superfamily, 
CYP7B1 contains heme iron as a cofactor. Human 
CYP7B1 shares 40% seq-uence identity with human 
CYP7A1, the other member of the CYP7 family. 
Expression 
Expression of CYP7B1 is reported in many human 
tissues including brain, kidney, liver, lung, heart, 
prostate, testis, ovary, placenta, pancreas, inteste, 
colon and thymus (Wu et al., 1999). 
 
 
Human CYP7B1 gene structure. Exons are represented by red bars with exon numbers at the bottom. 
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Localisation 
Most reports indicated localization to the membrane of 
the endoplasmic reticulum. There are some data 
indicating possible CYP7B1-related activity also in 
mitochondria but it is unclear whether this activity 
represents CYP7B1 or another enzyme species 
(Axelson et al., 1992; Pandak et al., 2002). 
Function 
CYP7B1 converts a number of steroids into their 
7alpha-hydroxyderivatives (Toll et al., 1994; Rose et 
al., 1997; Yau et al., 2006; Norlin and Wikvall, 2007). 
In addition to 7alpha-hydroxylation, forma-tion of 
6alpha, 6beta-, and 7beta-hydroxyderiva-tives also has 
been reported for this enzyme. Some well-known 
substrates for CYP7B1 are: 27-hydro-xycholesterol and 
25-hydroxycholesterol (choles-terol derivatives); 
dehydroepiandrosterone (DHEA) and pregnenolone 
(sex hormone precursors and neurosteroids); 5alpha-
androstane-3beta,17beta-diol and 5-androstene-
3beta,17beta-diol (estrogen recap-tor ligands). The 
catalytic reactions performed by CYP7B1 may lead to 
elimination of the steroids from the cell and thereby 
reduce the cellular levels of the substrates for this 
enzyme. Also, several of the products formed by 
CYP7B1 are reported to have physiological effects. 
Thus, CYP7B1 may in some cases be part of 
biosynthetic pathways to form active compounds. 
Homology 
The CYP7B1 gene is conserved in chimpanzee, dog, 
cow, mouse, rat, chicken, and zebrafish. 
Mutations 
Germinal 
A homozygous mutation in the CYP7B1 gene (R388X) 
was identified in an infant boy with defective bile acid 
synthesis and severe cholestasis (Setchell et al., 1998). 
The patient was the offspring of first cousins. 
Mutations in the CYP7B1 gene (S363F, G57R, R417H, 
F216S, R388X) have been associated with a form of 
hereditary spastic paraplegia (HSP type 5) 
characterized by motor neuron degeneration in affected 
individuals of several families (Tsaousidou et al., 
2008). S363F and F216S was predicted to affect 
phosphorylation of the mature protein. In addition, 
studies on non-consanguineous cases of hereditary 
spastic para-plegia indicate that a coding CYP7B1 
polymor-phism (c.971G>A) is associated with a 
phenotype of cerebellar signs believed to complicate a 
primary HSP phenotype (Schule et al., 2009). 
A functional polymorphism was reported in the human 
CYP7B1 promoter consisting of a C-G change located -
104 nucleotides from the trans-cription start site 
(Jakobsson et al., 2004). The C-G alteration at -104 
creates a putative C/EBPbeta binding site and was 
shown to result in higher transcriptional activity. In a  
study comparing allele frequency in an Oriental 
(Korean) population and a Caucasian (Swedish) 
population, the frequency of the uncommon G-allele 
was found to be much lower in the Oriental population 




High expression of CYP7B1 protein is found in high-
grade prostatic intraepithelial neoplasia (PIN) and 
adenocarcinomas (Olsson et al., 2007). Local 
methylation of the CYP7B1 promoter is suggested to 
be important for regulation of CYP7B1 in human 
prostate tissue. In addition, a functional C-G 
polymorphism in the CYP7B1 promoter has been 
associated with a different allele frequency in two 
ethnic populations with great differences in the 
incidence of prostate cancer (Swedes and Koreans) 
(Jakobsson et al., 2004). A connection between 
CYP7B1 and prostate cancer may be related to the 
action of estrogen receptor beta (ERbeta), since 
metabolism by CYP7B1 is reported to affect the levels 
of ligands for ERbeta, which is believed to have anti-
proliferative effects (Weihua et al., 2002; Martin et al., 
2004). Sex hormones are important for growth of 
prostate and other tissues, both during normal and 
malignant conditions. A potential role for CYP7B1 in 
tissue growth is supported by data indicating that t e 
Akt/PI3K (phosphoinositide 3-kinase) cascade, a 
signalling pathway important for cellular growth, 
affects the CYP7B1 gene (Tang et al., 2008). In human 
prostate cancer LNCaP cells, CYP7B1 promoter 
activity is affected by both androgens and estrogens, 
suggesting important functions in hormonal signallig 
(Tang and Norlin, 2006). 
Spastic Paraplegia Type 5A 
Note 
Mutations in the coding region of the CYP7B1 gene 
has been found in patients with spastic paraplegia type
5, an upper-motor-neuron degenerative disease which 
affects lower limb movement and results in extremity 
weakness and spasticity, sometimes accompanied by 
additional symptoms. Hereditary spastic paraplegia 
(HSP) is characterized by axonal degeneration of 
neurons in the corticospinal tracts and dorsal columns. 
Sequence alterations in CYP7B1, believed to affect the 
functionality of the enzyme, have been associated with 
a pure form of autosomal-recessive HSP in several 
families (Tsaousidou et al., 2008). The association of 
an abnormal CYP7B1 gene with this neurodegene-
rative condition suggest that the pathogenic basis for 
this disease is related either to effects on cholesterol 
homeostasis in the brain (i e on CYP7B1-mediated 
control of the levels of 27-hydroxycholesterol) or t  
effects on the metabolism of dehydroepiandrosterone 
and other neurosteroids. 
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Congenital Bile Acid Defect Type 3 
(CBAS3) 
Note 
A mutation in the CYP7B1 gene was linked to 
defective bile acid production, cholestasis and liver 
cirrhosis in an infant boy who died at the age of < 1 
year due to complications following liver trans-
plantation (Setchell et al., 1998). Other symptoms 
included hepatosplenomegaly, jaundice and increased 
bleeding. The pathological findings were consistent 
with accumulation of hepatotoxic unsaturated 
monohydroxy bile acids. The patient had 4,500 times 
higher levels of 27-hydroxycholes-terol than normal 
and liver samples showed no 27-hydroxycholesterol 
7alpha-hydroxylase activity. Failure to detect CYP7A1-
mediated 7alpha-hydroxylase activity in this patient as 
well as in other infants of the same age led the authors 
to suggest that CYP7B1 may be more important for 
bile acid synthesis in early life than in adulthood 
(Setchell et al., 1998). 
Alzheimer's Disease 
Note 
Some patients with Alzheimer's disease, a progress-sive 
neurodegenerative disease that strongly impairs 
cognition and memory, are reported to have altered 
levels of CYP7B1 expression and/or CYP7B1-formed 
metabolites. Some studies indi-cate reduced brain 
expression of CYP7B1 in Alzheimer's disease (Yau et 
al., 2003) whereas others report increased CYP7B1-
formed metabo-lites in serum from patients with this 
disease (Attal-Khemis et al., 1998). The potential 
role(s) of CYP7B1 in connection with Alzheimer's 
disease remains unclear. Alzheimer's disease is 
associated with build-up of neuritic plaques and 
neurofibrillary tangles and progressive loss of neurons 
and synapses in several parts of the brain. The etiology 
of Alzheimer's disease is not well understood and the 
underlying mechanisms are most likely complex. It has 
been suggested that disturbed metabolism of 
neurosteroids and/or other brain lipids may be one f 
the contributing factors (Yau et al., 2003; Bjorkhem t 
al., 2006). In some types of brain cells, CYP7B1-
dependent hydroxylation is the main metabolic fate or 
neurosteroids dehydro-epiandrosterone and 
pregnenolone. Also, the levels of CYP7B1 are higher in 
the hippocampus than in other parts of the brain, 
supporting a potential role for this enzyme related o 
memory and cognition (Yau et al., 2003). 
Rheumatoid Arthritis and Inflammation 
Note 
Increased production of the CYP7B1-formed  
metabolite 7alpha-hydroxy-DHEA has been suggested 
to contribute to the chronic inflammation observed in 
patients with rheumatoid arthritis (Dulos et al., 2005). 
Rheumatoid arthritis is a chronic inflammatory disorder 
with unclear etiology characterized by joint 
inflammation and progressive destruction of the joints. 
Other tissues also may be affected. Studies in a mouse 
model for collagen-induced arthritis indicate 
correlation of increased CYP7B1 activity with disea 
progression (Dulos et al., 2004). In humans, CYP7B1 is 
found in synovial tissues (connective tissues 
surrounding the joints) from patients with rheumatoid 
arthritis and CYP7B1 levels are up-regulated by 
proinflammatory cytokines in human synoviocytes 
(Dulos et al., 2005). Chronic inflam-matory diseases 
including rheumatoid arthritis are known to be 
associated with changes in levels of several steroids. It 
has been proposed that the CYP7B1-formed 7alpha-
hydroxy-DHEA might counteract the 
immunosuppressive effects of gluco-corticoids, which 
are used in treatment of rheuma-toid arthritis. 
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